Rhumbline Advisers Astellas Pharma Inc Unsponsore Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ALPMY
# of Institutions
5Shares Held
208KCall Options Held
0Put Options Held
0-
Hantz Financial Services, Inc.164KShares$1.66 Million0.03% of portfolio
-
Gamma Investing LLC Foster City, CA6.18KShares$62,5930.01% of portfolio
-
Private Capital Group, LLC1.09KShares$11,0010.01% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA40Shares$4050.0% of portfolio
About Astellas Pharma Inc Unsponsore
- Ticker ALPMY
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,827,069,952
- Market Cap $18.5B